What changed from existing technology?
This study compared two different approaches to giving blood transfusions to cancer patients in the ICU who have a severe infection called sepsis. One approach gives transfusions more freely, while the other is more cautious. The study looked at how these different approaches affect patient survival.
This study is the first to specifically examine the impact of transfusion practices on survival in oncology patients with sepsis in the ICU, addressing a gap in the current understanding of optimal transfusion strategies for this patient population.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 2
trictive transfusion practices on survival in oncology patients with sepsis in the intensive care unit. Red blood cell (RBC) transfusion is a commonly utilize
Title ↗ransfusion practice in oncologic patients with sepsis remains controversial. This study aimed to compare the clinical outcomes of liberal versus restrict
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This study may inform clinical guidelines for transfusion practices in oncology patients with sepsis, helping to optimize patient care and outcomes in critical care settings.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.